BRINGING NEW INSIGHT TO THE UNDERSTANDING OF SEVERE ASTHMA & BIOLOGICAL THERAPY.
IF YOU ARE STAFF AT ONE OF THE STUDY SITES PLEASE FIND RELEVANT STUDY INFORMATION BY CLICKING ON ”STAFF PLATFORM”
THE MISSION IS TO CONDUCT INTERNATIONAL CUTTING EDGE
RESEARCH THAT WILL BENEFIT PATIENTS WITH SEVERE ASTHMA.
WE ARE AIMING FOR A FUTURE WHERE THE RIGHT DRUG
WILL ALWAYS BE GIVEN TO THE RIGHT PATIENT AT THE RIGHT TIME
3TR-ABC is multicenter, observational,
prospective cohort study that follows patients
with severe asthma from the start of biological therapy
and up to 3 years onwards.
CONSTANTLY TAKING SMALL STEPS.
SEE HOW FAR WE HAVE COME.
Check out the news to find out about
new study sites, requitement goals,
research results and much more!
WE ARE BETTER TOGETHER
The study is anchored within the European 3TR Consortium.
The Consortium will align and integrate the analysis of autoimmune,
allergic, and inflammatory conditions to identify the relationship
between longitudinal molecular and microbiome profiles in blood cells
and tissues, and disease paths.